Respiratory      Neonatology                                                                                                                                                                                                                                                     
  • Home
  • |
  • Contact us
  • |
  • Chiesi Group
  • CN
  • EN

Enter at least 3 characters
  • About us
    • Our company and history
    • Chiesi China and big events
    • Chiesi mission
    • Values
    • B Corp and Benefit Society
  • Therapeutic areas
    • Respiratory
    • Neonatology
  • product
  • Research and development
    • Pipeline
    • Production plants
  • Career development
    • Leading quality
    • Sincere cooperation
    • People first
    • Welfare constant companion
    • Recruit
  • Media
    • News and press release
    • 2024 Sustainability Report
    • For the fourth time, Chiesi China has joined hands with the "Desert Border Forest Initiative" to contribute to building a beautiful China
    • -
    • Shanghai Soong Ching Ling Foundation and Chiesi China have entered into a three-year cooperation agreement to jointly focus on elderly health
    • -
    • -
    • -
    • Chiesi Group releases 2023 Sustainability Report
    • 凯西中国荣登2024年《财富》中国ESG影响力榜
    • In 2023, the Chiesi Group's revenue exceeded 3 billion euros, demonstrating its commitment to continuous innovation and sustainable development
    • -
    • Dr. Paolo Chiesi, Honorary President of Casey Group
    • -
    • Chiesi China Upgrades its ‘Marco Polo’ Project at the 6th CIIE with Signing Strategic Partnership with Shanghai Pharmaceuticals Co., Ltd.
    • Countdown to 30 days | Chiesi appointment to enter the 2023 blog again
HOME > Chiesi Press Release > Chiesi
  • Media
  • News and press release
  • 2024 Sustainability Report
  • For the fourth time, Chiesi China has joined hands with the "Desert Border Forest Initiative" to contribute to building a beautiful China
  • -
  • Shanghai Soong Ching Ling Foundation and Chiesi China have entered into a three-year cooperation agreement to jointly focus on elderly health
  • -
  • -
  • -
  • 凯西中国荣登2024年《财富》中国ESG影响力榜
  • In 2023, the Chiesi Group's revenue exceeded 3 billion euros, demonstrating its commitment to continuous innovation and sustainable development
  • -
  • Dr. Paolo Chiesi, Honorary President of Casey Group
  • -
  • Chiesi China Upgrades its ‘Marco Polo’ Project at the 6th CIIE with Signing Strategic Partnership with Shanghai Pharmaceuticals Co., Ltd.
  • Countdown to 30 days | Chiesi appointment to enter the 2023 blog again
  • -
  • ”Silent Killer“——Attention should be paid to the risk management of acute exacerbation of chronic obstructive pulmonary disease
  • Financial Report | Casey Group's International Market Business, including China, Continues to Grow in 2022
  • Hand in hand with the
  • -
  • -
  • -
  • -
  • Chiesi earns B Corp Certification Again, Sets More Challenging 2025 Action Goals
  • To build a healthier and more sustainable future, Chiesi continues to promote related initiatives
  • -
  • -
  • -
  • -
  • Chiesi_Bayer_China_Parternship_PressRelease

Chiesi

-

© 2025 Chiesi Pharmaceutical (Shanghai) Co., Ltd
Unit 601、602、603、605、606,Building 3, Lane 1398,Kaixuan Road Shanghai 200052
Telephone +86 21 52588899

  • Sitemap
  • Cookies
  • Credits
  • CHIESI CODE OF INTERDEPENDENCE
  • Pharmacovigilance
  • SPEAKUP&BEHEARD
  • CHIESI CODE OF CONDUCT
  • Anti-Bribery Policy
  • Terms of use
  • Privacy
  • -
  • SPEAKUP & BEHEARD
CHIESI ON THE WEB
CHIESI ON THE WEB
Belgique
Chiesi sa
Brésil
Chiesi Farmacêutica Ltda
Bulgarie
Chiesi Bulgaria Ltd.
Chine
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Allemagne
Chiesi GmbH
Grèce
Chiesi Hellas Pharmaceuticals S.A.
Royaume Uni
Chiesi Ltd
Italie
Divisione Farmaceutica Italia
Mexique
Chiesi Mexico S.A. de C.V.
Pays-Bas
Chiesi Pharmaceuticals B.V.
Autriche
Chiesi Pharmaceuticals GmbH
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Pologne
Chiesi Polonia
Roumanie
Chiesi România S.r.l.
La Fédération de Russie
Chiesi Pharmaceuticals LLC
Suède
Chiesi Pharma AB
Slovaquie
Chiesi Slovakia s.r.o
Slovénie
Chiesi Slovenija, d.o.o
Espagne
Chiesi España S.A.
République Tchèque
Chiesi CZ s.r.o.
Turquie
Chiesi İlaçTicaret Limited Sirketi  A.Ş.
Hongrie
Chiesi Hungary Kft.
Etats-Unis
Chiesi Usa Inc.